Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 622.10
+9.25 (1.51%)
At close: Aug 17, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 12.28 billion as of August 17, 2026. Its market cap has increased by 12.85% in one year.
Market Cap
12.28B
Enterprise Value
9.91B
Revenue
7.03B
Ranking
n/a
PE Ratio
12.73
Stock Price
622.10
ChartMarket Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 12.28B, an increase of 8,737.15%. That is a compound annual growth rate of 22.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 12.46B | 28.75% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shukra Pharmaceuticals | 18.21B |
| TTK Healthcare | 16.40B |
| Amrutanjan Health Care | 14.30B |
| Syncom Formulations (India) | 14.02B |
| Fermenta Biotech | 13.14B |
| Kopran | 9.64B |
| Bharat Parenterals | 9.30B |
| Wanbury | 9.13B |